A multinational collaboration co-led by the Garvan Institute of Medical Research has uncovered a potential explanation for why some cancer patients receiving a type of immunotherapy called checkpoint ...

While boosting T cell cancer-fighting ability, checkpoint inhibitors may reduce the body's production of protective antibodies that fight common infections. A multinational collaboration co-led by the ...

A multinational collaboration co-led by the Garvan Institute of Medical Research, in collaboration with Rockefeller University, and Kyoto University Graduate School of Medicine, has uncovered a ...